Now livetag icon
Who's really winning the World Cup economy? The data is in!Get the snapshotbanner icon
T-Knife GmbH

May 2026

T-Knife GmbH Market Share Analysis for May 2026

t-knife therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer.
Industry: N/A
Year Founded2018
Employees51 - 200
Annual Revenue$2M - $5M
t-knife.com
T-Knife GmbH
T-Knife GmbH (including company regionals)
  • t-knife.com
    t-knife.com
See more website traffic and engagement information

T-Knife GmbH Revenue up to May 2026 is 2M - 5M

revenue generated by T-Knife GmbH top domains

T-Knife GmbH top domains revenue over 3 years

Revenue for T-Knife GmbH top domains


Total visits to T-Knife GmbH's top domains

Understand T-Knife GmbH market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in T-Knife GmbH's top domains

Analyze T-Knife GmbH engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on T-Knife GmbH's top domains

See how T-Knife GmbH keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.


T-Knife GmbH top competitors by domain

Looks like there’s not enough data here

No Data to Display

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.


Top technologies used by T-Knife GmbH

These are the website technologies, by industry, used by T-Knife GmbH top domains

Widget (4)

Twemoji

Twemoji

Conversion & Analytics (2)

Google Analytics

Google Analytics

Mobile (2)

Meta Viewport

Meta Viewport

Advertising (1)

PubMatic

PubMatic

More Technologies

8

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from T-Knife GmbH

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsT-knife GmbH launches Phase 1 trial of CRISPR T cell therapy.T-knife launches Phase 1 trial of CRISPR T cell therapy.
NewsT-knife GmbH is developing Clinical Trial Application on Mar 3rd '26.San Francisco, CA and Berlin, Germany - March 3, 2026 - T-knife Therapeutics, Inc., a biopharmaceutical company developing next-generation T cell therapies to fight cancer, today announced the authorization of its Clinical Trial Application (CTA) to begin the Phase 1 ATLAS trial of TK-6302 in Europe.
NewsT-knife GmbH hires Christoph Broja as Board of Directors.T-knife Therapeutics appoints Christoph Broja to its Board of Directors.

See all T-Knife GmbH signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.